Mediclinic International plc Director/PDMR Shareholding (0590H)
June 02 2017 - 10:00AM
UK Regulatory
TIDMMDC
RNS Number : 0590H
Mediclinic International plc
02 June 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
2 June 2017
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Awards under the Company's Short-Term Incentive Scheme
On 1 June 2017, awards over ordinary shares in Mediclinic (the
"Shares") were granted to the following Directors and other persons
discharging managerial responsibilities ("PDMRs") under the rules
of the Company's Short-Term Incentive ("STI") Scheme, which was
approved by shareholders in December 2015:
Name Director/ Number of Shares awarded
PDMR under the Short Term
Incentive Scheme
----------------- ----------- -------------------------
Danie Meintjes Director 27,187
----------------- ----------- -------------------------
Jurgens Myburgh Director 10,815
----------------- ----------- -------------------------
Nil consideration per share was paid for the grant of the
awards. The vesting of an award is subject to employment
conditions; no further performance conditions apply.
The following notification made in accordance with Articles 19.1
and 19.3 of the Market Abuse Regulation relates to the Company's
STI Scheme.
1. Details of PDMR / person closely associated
with them ("PCA")
--- -------------------------------------------------------------
a) Name Daniël Petrus Meintjes
--- --------------------- --------------------------------------
2. Reason for the notification
--- -------------------------------------------------------------
a) Position Chief Executive Officer of the
/ status Company
--- --------------------- --------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- --------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- --------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- --------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- --------------------------------------
b) Nature of Award over ordinary shares in
the transaction Mediclinic International plc granted
under the Company's Short Term
Incentive Scheme
--- --------------------- --------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ---------- ----------
Nil cost 27,187
---------- ----------
--- --------------------- --------------------------------------
d) Aggregated
information
Aggregated
volume 27,187
Price
ZAR0.00
--- --------------------- --------------------------------------
e) Date of the 1 June 2017
transaction
--- --------------------- --------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- --------------------------------------
1. Details of PDMR / person closely associated
with them ("PCA")
--- -------------------------------------------------------------
a) Name Petrus Jurgens Myburgh
--- --------------------- --------------------------------------
2. Reason for the notification
--- -------------------------------------------------------------
a) Position Chief Financial Officer of the
/ status Company
--- --------------------- --------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- --------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- --------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- --------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- --------------------------------------
b) Nature of Award over ordinary shares in
the transaction Mediclinic International plc granted
under the Company's Short Term
Incentive Scheme
--- --------------------- --------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ---------- ----------
Nil cost 10,815
---------- ----------
--- --------------------- --------------------------------------
d) Aggregated
information
Aggregated
volume 10,815
Price
ZAR0.00
--- --------------------- --------------------------------------
e) Date of the 1 June 2017
transaction
--- --------------------- --------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- --------------------------------------
About Mediclinic International plc
Mediclinic is an international private healthcare group with
operating platforms in Southern Africa (South Africa and Namibia),
Switzerland and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care,
specialist-orientated, multi-disciplinary healthcare services.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic
Southern Africa operates 49 hospitals and 2 day clinics throughout
South Africa and 3 hospitals in Namibia with more than 8 000
inpatient beds in total; Hirslanden operates 16 private acute care
facilities and 4 clinics in Switzerland with more than 1 600
inpatient beds; and Mediclinic Middle East operates 6 hospitals and
31 clinics with more than 700 inpatient beds in the United Arab
Emirates.
During February 2016, the combination of the Company (previously
named Al Noor Hospitals Group plc), with operations mainly in Abu
Dhabi in the United Arab Emirates, and Mediclinic International
Limited was completed. Mediclinic International Limited was a South
African based international private healthcare group founded in
1983 and listed on the JSE, the South African stock exchange, since
1986, with operations in South Africa, Namibia, Switzerland and the
United Arab Emirates (mainly in Dubai). The combination resulted in
the renaming of the enlarged group to Mediclinic International
plc.
Mediclinic has a primary listing on the Main Market of the LSE,
with secondary listings on the JSE in South Africa and the NSX in
Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH,
United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBSGDLXDGBGRD
(END) Dow Jones Newswires
June 02, 2017 11:00 ET (15:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024